Dabur India Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/hzvkrswfsdkd9leelk4w7tcu.pdf

Key Takeaways


India Demand & Portfolio Performance

Mohit Malhotra: "But Nielsen data is the only dampener that I see, and they are showing that FMCG growth has got muted from 11% to 9%. That said, 9% is also very respectable growth out of which partial is volume and partially is pricing, but there's been a sequential decrease. I don't know if Nielsen is a lead indicator of things to come because inflation is picking up and because of inflation, volumes will get suppressed and price hikes will come in. So that's something which is a dichotomy, which I am not able to unfold."

Oral Care: The Problem Child

Mohit Malhotra: "So not at all. I think we're not even at a threshold of satisfaction in terms of happiness index. We are quite unhappy with this performance because entire HPC portfolio has grown by 17% with oral care being a outlier where we've seen a muted performance of around 6%, 7% growth in Oral Care."

Inflation, Pricing & Margin Strategy

Mohit Malhotra: "we will prioritize our margin over our media spend going forward. While we are committed doing more media and doing demand, but when the inflation is very high, it's better to protect the base business."

International Business: Middle East Weighs


Strategic Initiatives & Portfolio Shifts

Mohit Malhotra: "we are bursting from scenes in terms of capacity, and we are augmenting capacity as we go on. And we'll be producing this. And whatever we are producing is what we are selling."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthHigh single to low double-digit growth (revised from high single-digit); ~50% from volume, balance from pricingFY27
Oral Care growthReturn to very strong double-digit growth, led by Dabur Red, Meswak, Dabur HerbalQ1 FY27
HPC growthDouble-digit growth at a bare minimum; if not high teensFY27
F&B growthDouble-digit growth for the full year, based on low base and assumption season plays outFY27
Coconut Water ARRExit rate of ₹150–200 cr (from current ~₹100 cr)FY27 exit
Margin expansionIncrease margins year-on-year; will not compromise margins; Q1 attempt to at least maintain India marginsFY27, with Q1 visibility
International growthDouble-digit growth (volume down, pricing up, plus rupee depreciation translation gain)FY27
Price increasesSecond round of price increases to be taken after considering war situationConditional on Middle East conflict evolution

Key Metrics

MetricQ4 FY26
Consolidated revenue growth7.3% YoY
Domestic FMCG revenue growth9.5% YoY, with volume growth of 6%
Consolidated operating profit growth8.2% YoY
Reported PAT growth15% YoY
HPC portfolio growth17% YoY
Hair Oil portfolio growth28% YoY, volume market share gain of 154 bps
Shampoo portfolio growth20% YoY
Home Care portfolio growth24% YoY
Toothpaste portfolio growth7.2% YoY
Health care portfolio growth ex-glucose~12.5% YoY
International business growth2.5% YoY in INR terms
FY27 revenue growth guidanceHigh single-digit to low double-digit, revised from high single-digit; 50% from volume, balance from pricing
Input cost inflation~10% across many portfolios
Price increases announced4% across different parts of the business
Quick commerce salience in e-commerce75%, up from 50% in Q3; growth rate of 50%